You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Iodine-131

Showing 1 - 25 of 888
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Device Trial in Vandœuvre-lès-Nancy (A SPECT-CT whole body is added in VERITON-CT camera)

Recruiting
  • Device
  • A SPECT-CT whole body is added in VERITON-CT camera
  • Vandœuvre-lès-Nancy, France
    Chru Nancy Brabois
Feb 1, 2023

Iodine-131 in Total(Near) Thyroidectomy Patients.

Completed
  • Thyroidectomy
    • New Taipei City, Taiwan
      Far Eastern Memorial Hospital
    Feb 22, 2022

    Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

    Available
    • Neuroblastoma
    • Childhood Metastatic Pheochromocytoma
    • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
    • 131 I-MIBG
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jul 11, 2022

    Thyroid Cancer Trial in New York (131 I-iodine (131-I), 124 I-iodine (124-I))

    Active, not recruiting
    • Thyroid Cancer
    • 131 I-iodine (131-I), 124 I-iodine (124-I)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

    Completed
    Has Results
    • Kidney Cancer
    • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Thyroid Cancer Trial in Peking (Apatinib)

    Completed
    • Thyroid Cancer
    • Peking, China
      Peking Union Medical College Hospital
    Jan 18, 2022

    Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

    Active, not recruiting
    Has Results
    • Multiple Myeloma
    • Iodine I 131 Tositumomab
    • Ann Arbor, Michigan
      University of Michigan
    Mar 16, 2022

    Renal Tracer Elimination in Thyroid Cancer Patients Treated With

    Completed
    • Thyroid Carcinoma
      • Jena, Thüringen, Germany
        University Hospital Jena
      Dec 15, 2022

      Collect Images in Patients Treated With Iodine-131 as Part

      Completed
      • Differentiated Thyroid Cancer
        • Toulouse, France
          IUCT-O
        May 26, 2021

        Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

        Not yet recruiting
        • Thyroid Cancer
        • +5 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Dec 20, 2022

        Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))

        Not yet recruiting
        • Thyroid Cancer
        • Bialystok, Poland
          Department of Endocrinology, Diabetology and Internal Medicine,
        Jul 26, 2022

        Thyroid Nodule, Toxic or With Hyperthyroidism, Autonomous Thyroid Function, Thyroid Nodule; Hyperthyroidism Trial in Arnhem,

        Recruiting
        • Thyroid Nodule, Toxic or With Hyperthyroidism
        • +5 more
        • Radiofrequency ablation
        • Radioactive iodine
        • Arnhem, Gelderland, Netherlands
        • +1 more
        Dec 2, 2021

        Colorectal Tumors Trial in Heidelberg (Capecitabine, 131I-huA33 (131-Iodine on humanised mAb A33))

        Completed
        Has Results
        • Colorectal Neoplasms
        • Capecitabine
        • 131I-huA33 (131-Iodine on humanised monoclonal antibody A33)
        • Heidelberg, Victoria, Australia
          Ludwig Institute Oncology Unit and Tumor Targeting Program, Aust
        Jan 11, 2022

        Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

        Active, not recruiting
        • Brain and Central Nervous System Tumors
        • +9 more
        • DNA analysis
        • +4 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Oct 28, 2021

        Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

        Active, not recruiting
        • Mantle Cell Lymphoma
        • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
        • Basking Ridge, New Jersey
        • +4 more
        Dec 1, 2022

        Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

        Terminated
        • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
        • +9 more
        • Allogeneic Bone Marrow Transplantation
        • +7 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Oct 4, 2021

        Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

        Active, not recruiting
        Has Results
        • Disseminated Neuroblastoma
        • +5 more
        • Birmingham, Alabama
        • +22 more
        Mar 3, 2022

        Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

        Active, not recruiting
        • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
        • Villejuif, Val De Marne, France
          Gustave Roussy
        Sep 27, 2021

        Non Toxic Multinodular Goiter, High Intensity Focused Ultrasound, RAI Trial in Hong Kong (Echopulse, Radioactive iodine

        Not yet recruiting
        • Non Toxic Multinodular Goiter
        • +2 more
        • Echopulse
        • Radioactive iodine (Radioidine i131)
        • Hong Kong, Hong Kong
          Queen Mary Hospital
        Apr 27, 2021

        Lymphoma, Mantle-Cell Trial (Tositumomab and Iodine I 131 Tositumomab followed by CHOP)

        Completed
        Has Results
        • Lymphoma, Mantle-Cell
        • Tositumomab and Iodine I 131 Tositumomab followed by CHOP
        • (no location specified)
        Nov 19, 2019

        Neuroblastoma Trial in Lund (iodine I 131 metaiodobenzylguanidine, Fludarabine, Thiotepa)

        Active, not recruiting
        • Neuroblastoma
        • iodine I 131 metaiodobenzylguanidine
        • +7 more
        • Lund, Sweden
          Lund University Hospital, Department of Pediatric Oncology and B
        Feb 17, 2021

        Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma Trial in Seattle

        Terminated
        Has Results
        • Recurrent B-Cell Non-Hodgkin Lymphoma
        • +5 more
        • Autologous Hematopoietic Stem Cell Transplantation
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Mar 26, 2020

        Thyroid Cancer Trial in Worldwide (Lenvatinib (DTC Cohort), Lenvatinib (MTC Cohort))

        Completed
        Has Results
        • Thyroid Cancer
        • Lenvatinib (DTC Cohort)
        • Lenvatinib (MTC Cohort)
        • Little Rock, Arkansas
        • +41 more
        Apr 3, 2020

        Differentiated Thyroid Cancer Trial (Low iodine diet)

        Not yet recruiting
        • Differentiated Thyroid Cancer
        • Low iodine diet
        • (no location specified)
        Oct 25, 2022

        Thyroid Disease Trial in Syracuse (SPECT)

        Enrolling by invitation
        • Thyroid Disease
        • SPECT
        • Syracuse, New York
          SUNY Upstate Medical University
        Aug 31, 2023